The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer

Preclinical studies have demonstrated the synergistic anti-tumour activity of combination therapy with the oral cytostatics, 5′-deoxy-5-fluorouridine (5′-DFUR) and cyclophosphamide (CPA), in human breast cancer xenograft models. This study was performed to evaluate the efficacy and safety of this or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimoto, M, Tada, K, Tokudome, N, Kutomi, G, Tanabe, M, Goto, T, Nishimura, S, Makita, M, Kasumi, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394400/
https://www.ncbi.nlm.nih.gov/pubmed/14583760
http://dx.doi.org/10.1038/sj.bjc.6601350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394400/
https://www.ncbi.nlm.nih.gov/pubmed/14583760
http://dx.doi.org/10.1038/sj.bjc.6601350

Ejemplares similares